Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2025-12-31 @ 2:28 PM
Study NCT ID:
NCT01373606
Status:
COMPLETED
Last Update Posted:
2012-02-14
First Post:
2011-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
Sponsor:
Ferring Pharmaceuticals
Organization:
Study Overview
Official Title:
An Exploratory Study of FE999908 in Patients With Hepatorenal Syndrome Type 1
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HRS
Brief Summary:
This is an open-label, multi-center study, investigating the efficacy and safety of terlipressin in Japanese patients with hepatorenal syndrome type 1.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: